Inhibikase Therapeutics IKT
NASDAQ IKT
$1.66 -0.05 (-2.92%)
At close: Oct 21, 2026 · 4:00 PM EDT

Inhibikase Therapeutics (IKT) Shares Repurchased (2020)

Updated

Analysis

Inhibikase Therapeutics (IKT) Shares Repurchased (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 221.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 9.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 355.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Inhibikase Therapeutics 288.92 Mn -296.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 67,132.00
API Access

Inhibikase Therapeutics Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=IKT&period=max&api_key=YOUR_API_KEY